Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus
- 20 December 2003
- journal article
- research article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 269 (1), 29-35
- https://doi.org/10.1016/j.ijpharm.2003.07.013
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Efficacy and Safety of Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in ChildrenPublished by American Academy of Pediatrics (AAP) ,2002
- Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescentsJournal of the American Academy of Dermatology, 2002
- New and Established Topical Corticosteroids in DermatologyAmerican Journal of Clinical Dermatology, 2002
- ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral CompoundsJournal of Medicinal Chemistry, 2001
- A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacologyBritish Journal of Dermatology, 1999
- TacrolimusDrugs, 1997
- A new approach to analysis and display of local lipophilicity/hydrophilicity mapped on molecular surfacesJournal of Computer-Aided Molecular Design, 1993
- Fast generation of molecular surfaces from 3D data fields with an enhanced “marching cube” algorithmJournal of Computational Chemistry, 1993
- Side Effects of Topical Corticosteroids and their PreventionDrugs, 1988
- Atomic Physicochemical Parameters for Three‐Dimensional Structure‐Directed Quantitative Structure‐Activity Relationships I. Partition Coefficients as a Measure of HydrophobicityJournal of Computational Chemistry, 1986